This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?
by Debasmita Chatterjee
UHS witnesses revenue growth from increased patient volumes and strategic initiatives. An extensive treatment network remains an added strength.
Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?
by Zacks Equity Research
SEM's profitability is being impacted by rising costs and expenses.
Is Trending Stock Tenet Healthcare Corporation (THC) a Buy Now?
by Zacks Equity Research
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Teladoc Stock Rises 12% as Jefferies Boosts Price Target on BetterHelp
by Zacks Equity Research
TDOC's stock benefits from improving web traffic in its BetterHelp platform.
HCA Healthcare Stock Up 18.4% in 3 Months: Can You Afford to Miss Out?
by Zubia Masood
HCA benefits from expanding insurance coverage, rising demand and improving margins.
Are You Looking for a Top Momentum Pick? Why Tenet Healthcare (THC) is a Great Choice
by Zacks Equity Research
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Community Health's Arm Northwest Urgent Buys 10 Arizona Facilities
by Zacks Equity Research
CYH expects the acquisition from Carbon Health to be completed in the fourth quarter of 2024.
Tenet Healthcare (THC) Rises Higher Than Market: Key Facts
by Zacks Equity Research
The latest trading day saw Tenet Healthcare (THC) settling at $164.62, representing a +1.36% change from its previous close.
Pediatrix Medical Up 45.8% in 3 Months: Is it Too Late to Jump In?
by Zacks Equity Research
MD remains one of the best-positioned pediatric service providers with favorable valuation to achieve margin improvement.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain
by Zacks Equity Research
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
3 Momentum Anomaly Stocks to Buy as Markets Soar on Cooling Inflation
by Supriyo Bose
PPC, THC and MTG are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Why Brookdale May Not Be a Safe Bet Despite 34-Month Occupancy Growth
by Zacks Equity Research
Rising operating costs due to inflationary challenges in the senior living industry and higher estimated insurance expenses are likely to keep BKD's margins under pressure.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Breaking Down Common Investing Strategies
by Derek Lewis
Income investors seek steady payouts, growth investors seek companies expected to grow at an above-average pace, and value investors seek deals hidden in plain sight.
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
by Zacks Equity Research
The latest trading day saw Tenet Healthcare (THC) settling at $154.62, representing a +0.91% change from its previous close.
Here's Why Universal Health Shares are Attracting Investors Now
by Zacks Equity Research
UHS remains well-poised for growth on improved patient days at its behavioral healthcare facilities, acquisitions and solid cash flows.
Should Vanguard S&P Mid-Cap 400 Value ETF (IVOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOV
Here's How Much You'd Have If You Invested $1000 in Tenet Healthcare a Decade Ago
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Elevance Health Stock Has More to Offer: Should You Hold on Tight?
by Zacks Equity Research
In the commercial category, an increase in individual as well as employer group fee-based memberships will continue supporting ELV's medical membership numbers.